
The study evaluated AF‐specific medical therapies and post‐discharge outcomes among patients hospitalized for heart failure with mildly reduced ejection fraction (HFmrEF) or HFpEF by AF history. Trends in AF prevalence were evaluated among patients hospitalized for HFmrEF or HFpEF in the Get with The Guidelines‐Heart Failure registry from 2014 to 2020. The prevalence of AF is rising among patients hospitalized with HFpEF. Those with comorbid AF face elevated post‐discharge risks of death and rehospitalization. The current use of pharmacological rhythm control is low.
Like
Save
Share